Refine by
Clinical Immunology Articles & Analysis
24 news found
Medical Equipment Pump Solutions Industry Overview IVD, which stands for in vitro diagnostics, refers to products that conduct testing on samples taken from the human body (such as blood, body fluids, and tissues) outside of the body in order to obtain clinical diagnostic information. The IVD industry is subdivided into various sectors including immunodiagnostics, ...
Everyone unanimously approved and applauded the exhibited products which included the PreMed 5200 liquid chromatography tandem mass spectrometry system, GeneTOF 3100 nucleic acid mass spectrometry system, ClinCap 1000 fully automated capillary electrophoresis instrument, and MSFLO benchtop mass spectrometry flow cytometer among a few.Focusing on clinical diagnosis, EXPECLIN, a ...
The last patient in the investigator-initiated clinical trial DIAGNODE-B has received its additional injection (“booster”) of the therapeutic diabetes vaccine Diamyd®. ...
Regor Therapeutics Group, a clinical-stage biotech company focusing on immunology, oncology, and metabolic disorders, announced today that the first patient has been dosed in the Phase II clinical trial of the Company’s novel oral small molecule GLP-1 receptor agonist RGT-075 in the U.S. ...
Regor Therapeutics Group, a clinical-stage biotech company focusing on immunology, oncology, and metabolic disorders, announced today that the first patient has been dosed in the Phase I clinical trial of the Company’s next generation targeted inhibitor RGT-419B for the treatment of breast cancer. ...
From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. ...
GAITHERSBURG, Md., Dec. 12, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced preliminary Phase 1/2 results from an ongoing study of NEXI-002, a patient-derived ...
“We are very excited to see early signs of clinical activity in the TG4050 clinical trials that uses our AI-driven neoantigen prediction system. ...
” By incorporating Nebion’s public datasets with data Immunai has gathered, Jacobstein said, Immunai will be able to expand its Annotated Multiomic Immunological Cell Atlas (AMICA), the company’s harmonized single-cell immunology database, with advanced transfer and multi-task learning algorithms. ...
ByImmunai
Initial clinical data from the trial are expected in 2022. EO2463 is an innovative, off-the-shelf microbiome-peptide based cancer vaccine that combines four microbiome-peptides of B lymphocyte-specific lineage markers. ...
ByEnterome
Hichem Chakroun as Executive VP, Clinical Development. As EVP, Hichem will apply his industry expertise and experience to help accelerate the strategy of Ariana in the clinical trials setting. ...
Massari is based in Boston and will oversee clinical development and contribute to expanding the company’s AI platform and therapeutic portfolio. “In a short period of time, our artificial intelligence platform has unlocked dozens of novel therapeutic opportunities for addressing patients with rare genetic disorders,” said Brendan Frey, Founder and Chief ...
Curtis, Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB), and national Co-Principal Investigator for SetPoint Medical’s upcoming pivotal trial of VNS in patents with RA. ...
Curtis, Professor of Medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham (UAB), and national Co-Principal Investigator for SetPoint Medical’s upcoming pivotal trial of VNS in patents with RA. ...
Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out millions of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. The company is also announcing $20M in seed funding, which will be used to further the development of its technology and business functions ...
ByImmunai
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. ...
The ATRACTion project will generate clinical, multi-omic (single cell RNA expression, gut microbiota) and additional immunological data by investigating several auto-immune diseases. ...
As pioneers of products that assist in ground-breaking discoveries in science and clinical care, we have a strong network of academic and industry partners. ...
ByBaker
This was reflected by the huge amount of international professional visitors of this year’s annual EAACI 2019 (congress of the European Academy of Allergy and Clinical immunology) taking place in Portugal’s capital and harbor city Lisbon. ...
If we want to protect children, we have to protect pregnant women," says the study's senior author Rachel Miller, MD, professor of Medicine (in Pediatrics) and Environmental Health Sciences; and chief of Pediatric Allergy, Immunology, and Rheumatology at Columbia University Medical Center; and co-deputy director of the Columbia Center for Children's Environmental Health at ...